Harvard Bioscience, Inc. (FRA:HBI)
0.6050
-0.0050 (-0.82%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Instruments, Equipment, Software and Accessories | 86.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Instruments, Equipment, Software and Accessories Growth | -17.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service, Maintenance and Warranty Contracts | 7.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service, Maintenance and Warranty Contracts Growth | 9.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| United States | 41.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -13.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East and Africa | 28.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China | 13.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China Growth | -28.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia - Other | 7.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia - Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas - Other | 3.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|